Sleep Apnea Device Market Research Report Information By Type (Diagnostic Devices and Therapeutic Devices), By End User (Home Care Settings and Sleep Laboratories & Hospitals), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.

Global Sleep Apnea Device Market Overview

Sleep Apnea Device Market Size was valued at USD 5.5 billion in 2022 and is projected to grow from USD 5.9 Billion in 2023 to USD 8.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.52% during the forecast period (2023 - 2030). Growing public awareness, the aging population, the prevalence of the condition, and the need for better OSA diagnosis and treatment are a few of the major market drivers influencing the growth of the sleep apnea market.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Sleep Apnea Device Market Trends

• Growing incidence of bone disorders to propel market growth

Obstructive sleep apnea (OSA), which affects 18 million Americans, is thought to affect 1 in 15 persons in the country, according to research from Sleep Science Resource, LLC. People's sedentary lifestyles have increased the prevalence of obesity, disturbed sleep patterns, high levels of stress, and cardiovascular disorders. For instance, multiple cross-sectional studies have suggested that severe sleep apnea is prevalent in 40% of the obese population and that 70% of OSA patients are obese, according to the article published by American Heart Association, Inc. Also, between 13.0% and 32.0% of the elderly population in Europe had sleep apnea, according to data released by the European Respiratory Society. A sizable patient pool needs to be treated or managed for the illness due to rising rates of obesity and other lifestyle disorders, as well as rising sleep apnea diagnosis rates in both industrialised and developing nations. This, together with an increase in sleep clinics and sleep technicians worldwide, is promoting market expansion. Additionally, there is a sizable population of unidentified patients, particularly in underdeveloped nations. Through various efforts like "sleep awareness week," numerous groups and governmental organisations are concentrating on raising the awareness and diagnostic rates among these people. Additionally, it is projected that this will fuel market expansion over the upcoming years. Thus, this factor is driving the market CAGR for sleep apnea device.
Figure 1: Prevalence of Osteroarthritis

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Furthermore, the development of novel alternatives for the treatment of sleep apnea has been greatly aided by the shift of patients towards technologically improved gadgets. For instance, due to patient discomfort with CPAP machines, the usage of oral devices such the mandibular advancement device (MAD) for OSA treatment has increased. Additionally, it is estimated that the compliance rate for CPAP devices among users has decreased by up to 50.0%, according to data published by NCBI based on various studies carried out in different countries. This has caused the market to introduce alternatives like oral appliances, which have proven to be efficient and provide comfort to patients during the treatment of the disorder. Along with this, the non-invasive nature of the actometer and its lower price compared to conventional polysomnography equipment have made it extremely popular among sleep clinics (PSG). As a result, patients are increasingly turning to oral appliances and actometers for successful management of sleep apnea due to rising non-adherence for CPAP equipment and increased demand for affordable diagnostic gadgets. Thus, it is anticipated that this aspect will accelerate sleep apnea device market revenue globally. 

Sleep apnea device Market Segment Insights

Sleep Apnea Device Type Insights

The Sleep Apnea Device Market segmentation, based on type, includes Diagnostic Devices and Therapeutic Devices. The therapeutic devices segment held the majority share in 2022 in the Sleep Apnea Device Market data due to an increase in the number of diagnosed individuals receiving treatment at sleep clinics, particularly in wealthy nations, which includes CPAP therapy. Around 95% of Americans with diagnoses receive therapy, and CPAP is the most popular form of treatment among these patients, according to KOL interviews.

August 2021: ResMed, a leader in digital health and the treatment of sleep apnea, unveiled AirSense 11, its next-generation Positive Airway Pressure (PAP) device. This device is intended to help hundreds of millions of people with sleep apnea around the world begin and maintain treatment for managing obstructive sleep apnea.

Figure 2: Sleep Apnea Device Market, by Type, 2022 & 2030 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Sleep Apnea Device End User Insights

The Sleep Apnea Device Market segmentation, based on application, includes Home Care Settings and Sleep Laboratories & Hospitals. The home care settings segment dominated the market growth for sleep apnea device in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Players in the market are concentrating on producing novel, portable gadgets for patients receiving treatment for the ailment to use at home. The need for these devices in homecare and other settings is rising as a result of this and the growing desire for treating OSA at home, particularly in nations like the U.S., U.K., Germany, and Japan, among others.

Sleep Apnea Device Regional Insights

By region, the study provides the market insights for sleep apnea device into North America, Europe, Asia-Pacific and Rest of the World. North America sleep apnea device market accounted for USD 2.5 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The higher frequency of the illness and the advantageous reimbursement rules, which have been essential in the larger adoption of such devices in the region, are to blame for North America's supremacy. The American Academy of Sleep Medicine (AASM) estimates that in the United States, 2.0%-5.0% of women and 3.0%-7.0% of males suffer from sleep apnea.

Further, the major countries studied in the market report for sleep apnea device are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: SLEEP APNEA DEVICE MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe sleep apnea device market accounts for the second-largest market share. This is attributable to growing awareness of sleep apnea, as well as an increase in the need for diagnostic testing, a favourable reimbursement environment, and expanding device penetration in this area. For instance, on September 15, 2022, ProSomnus, a pioneer in precise medical devices for the management of OSA, announced that the German public health insurance system officially covers the ProSomnus EVOTM Sleep and Snore Device. Further, the UK sleep apnea device market held the largest market share, and the Germany sleep apnea device market was the fastest growing market in the region.

Asia Pacific sleep apnea device Market is expected to grow at the fastest CAGR from 2022 to 2030 due to the rising prevalence of lifestyle disorders such chronic respiratory illnesses, cancer, hypertension, and diabetes, as well as the growing senior population. As per the OECD iLibrary article on Asia/Pacific 2020, approximately 227 million individuals are diagnosed with type 2 diabetes in the Asia Pacific. Moreover, China sleep apnea device market held the largest market share, and the India sleep apnea device market was the fastest growing market in the region.

Sleep Apnea Device Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the sleep apnea device market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the sleep apnea device industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the global sleep apnea device industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, sleep apnea device industry has provided medicine with some of the most significant benefits. The sleep apnea device market major player such as ResMed, LivaNova, Nihon Kohden, GE Healthcare, Natus Medica, Cadwell, Curative Medical and Koninklijke Philips.

The medical equipment business ResMed Inc. is situated in San Diego, California. For the treatment of sleep apnea (with CPAP machines and masks, for example), chronic obstructive pulmonary disease (COPD), and other respiratory disorders, it primarily offers cloud-connected medical devices. Hundreds of thousands of ventilators and bilevel devices were created by ResMed to assist in treating COVID-19 patients' respiratory difficulties. In November 2022, ResMed and the biological sciences division of Alphabet Verily announced the launch of Primasun, an all-inclusive tool to assist employers and healthcare professionals in identifying people at risk for complicated sleep problems.

A multinational provider of medical technology, GE HealthCare Technologies Inc.,[4] doing business as GE Healthcare, is based in Chicago, Illinois. As of 2017, it produces and distributes radiopharmaceuticals and diagnostic imaging agents for imaging modalities used in medical imaging procedures. In September 2022, to hasten the digital transformation of healthcare throughout Europe, the Middle East, and Africa, GE Healthcare and Wayra partnered with seven health tech start-ups.

Key Companies in the sleep apnea device market includes

• ResMed


• LivaNova


• Nihon Kohden


• GE Healthcare


• Natus Medica


• Cadwell


• Curative Medical


• Koninklijke Philips

Sleep Apnea Device Industry Developments

October 2022: The launch of flexTAP, a premium lab-made oral appliance intended to treat individuals with snoring and mild to moderate obstructive sleep apnea, was announced by Airway Management, a maker of the most extensively studied custom oral appliances.

October 2021: For patients to receive a comprehensive whole-mouth treatment for OSA, Candid just established a strategic relationship with Vivos Therapeutics, a company that treats obstructive sleep apnea. Through this strategic alliance, adult patients will have access to orthodontic treatments from the same provider network as well as a diagnosis and treatment for OSA.

Sleep Apnea Device Market Segmentation

Sleep Apnea Device Type Outlook (USD Billion, 2018-2030)

• Diagnostic Devices


• Therapeutic Devices

Sleep Apnea Device End User Outlook (USD Billion, 2018-2030)

• Home Care Settings


• Sleep Laboratories & Hospitals

Sleep Apnea Device Regional Outlook (USD Billion, 2018-2030)

• 
  

  North America

  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• 
  

  Europe

  
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• 
  

  Asia-Pacific

  
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  

  Rest of the World

  
  
  
  
  • 
    

    Middle East

    
    
  
  
  • 
    

    Africa

    
    
  
  
  • 
    

    Latin America